Exact Mass: 245.1375

Exact Mass Matches: 245.1375

Found 76 metabolites which its exact mass value is equals to given mass value 245.1375, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Glutaminylvaline

(2S)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-3-methylbutanoate

C10H19N3O4 (245.1375)


Glutaminylvaline is a dipeptide composed of glutamine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Asparaginylisoleucine

(2S,3S)-2-{[(2S)-2-amino-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene]amino}-3-methylpentanoate

C10H19N3O4 (245.1375)


Asparaginylisoleucine is a dipeptide composed of asparagine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Valylglutamine

(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carbamoylbutanoic acid

C10H19N3O4 (245.1375)


Valylglutamine is a dipeptide composed of valine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Isoleucyl-Asparagine

2-[(2-Amino-1-hydroxy-3-methylpentylidene)amino]-3-(C-hydroxycarbonimidoyl)propanoate

C10H19N3O4 (245.1375)


Isoleucyl-Asparagine is a dipeptide composed of isoleucine and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Asparaginyl-Leucine

2-{[2-amino-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene]amino}-4-methylpentanoate

C10H19N3O4 (245.1375)


Asparaginyl-Leucine is a dipeptide composed of asparagine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Leucyl-Asparagine

2-[(2-Amino-1-hydroxy-4-methylpentylidene)amino]-3-(C-hydroxycarbonimidoyl)propanoate

C10H19N3O4 (245.1375)


Leucyl-Asparagine is a dipeptide composed of leucine and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Valyl-Gamma-glutamate

2-Amino-4-[(2-amino-3-methylbutanoyl)-C-hydroxycarbonimidoyl]butanoate

C10H19N3O4 (245.1375)


Valyl-Gamma-glutamate is a dipeptide composed of valine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

DL-Leucylglycylglycine

DL-Leucylglycylglycine

C10H19N3O4 (245.1375)


   
   

SCHEMBL18613826

SCHEMBL18613826

C10H19N3O4 (245.1375)


   
   
   
   
   
   
   

Leu-Gly-Gly

Leu-Gly-Gly

C10H19N3O4 (245.1375)


A tripeptide composed of one L-leucine and two glycine residues joined in sequence. CONFIDENCE standard compound; INTERNAL_ID 164

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Asn-Ile

2-(2-amino-3-methylpentanamido)-3-carbamoylpropanoic acid

C10H19N3O4 (245.1375)


A dipeptide obtained by formal condensation of the carboxy group of L-asparagine with the amino group of L-isoleucine.

   

Asn-leu

2-(2-amino-4-methylpentanamido)-3-carbamoylpropanoic acid

C10H19N3O4 (245.1375)


   

GLN-Val

2-(2-amino-3-methylbutanamido)-4-carbamoylbutanoic acid

C10H19N3O4 (245.1375)


   

Ile-Asn

2-(2-amino-3-carbamoylpropanamido)-3-methylpentanoic acid

C10H19N3O4 (245.1375)


A dipeptide formed from L-isoleucine and L-asparagine residues.

   

Leu-asn

2-(2-amino-3-carbamoylpropanamido)-4-methylpentanoic acid

C10H19N3O4 (245.1375)


A dipeptide composed of L-leucine and L-asparagine joined by a peptide linkage.

   

Val-Gln

2-(2-amino-4-carbamoylbutanamido)-3-methylbutanoic acid

C10H19N3O4 (245.1375)


A dipeptide formed from L-valine and L-glutamine residues.

   

Val-gglu

2-[2-amino-4-(C-hydroxycarbonimidoyl)butanamido]-3-methylbutanoic acid

C10H19N3O4 (245.1375)


   

GGlu-Val

2-(2-amino-3-methylbutanamido)-4-(C-hydroxycarbonimidoyl)butanoic acid

C10H19N3O4 (245.1375)


   

Gly-gly-ile

Glycylglycyl-l-isoleucine

C10H19N3O4 (245.1375)


A tripeptide composed of glycine, glycine and L-isoleucine residues joined in sequence.

   

Gly-gly-leu

Gly-gly-leu

C10H19N3O4 (245.1375)


A tripeptide composed of glycine, glycine and L-leucine residues joined in sequence.

   

H-D-Leu-Gly-Gly-OH

H-D-Leu-Gly-Gly-OH

C10H19N3O4 (245.1375)


   

(S)-Tert-Butyl (1,5-diamino-1,5-dioxopentan-2-yl)carbamate

(S)-Tert-Butyl (1,5-diamino-1,5-dioxopentan-2-yl)carbamate

C10H19N3O4 (245.1375)


   

Leucyl-glycyl-glycine

Leucyl-glycyl-glycine

C10H19N3O4 (245.1375)


   

H-Gly-Leu-Gly-OH

N-(N-Glycyl-L-leucyl)glycine

C10H19N3O4 (245.1375)


   
   

Glycyl-alanyl-valine

Glycyl-alanyl-valine

C10H19N3O4 (245.1375)


   

Glycine, L-alanyl-L-valyl-

Glycine, L-alanyl-L-valyl-

C10H19N3O4 (245.1375)


   
   

Asparaginyl-Leucine

Asparaginyl-Leucine

C10H19N3O4 (245.1375)


   

L-Valylglycyl-L-alanine

L-Valylglycyl-L-alanine

C10H19N3O4 (245.1375)


   

Glycine, L-isoleucylglycyl-

Glycine, L-isoleucylglycyl-

C10H19N3O4 (245.1375)


   

L-Valyl-L-alanylglycine

L-Valyl-L-alanylglycine

C10H19N3O4 (245.1375)


   

Asparagylisoleucine

Asparagylisoleucine

C10H19N3O4 (245.1375)


   

L-Leucyl-L-asparagine

L-Leucyl-L-asparagine

C10H19N3O4 (245.1375)


   

L-Isoleucyl-L-asparagine

L-Isoleucyl-L-asparagine

C10H19N3O4 (245.1375)


   
   
   
   
   

Glycyl-valyl-alanine

Glycyl-valyl-alanine

C10H19N3O4 (245.1375)


   

Leucylasparagine

Leucylasparagine

C10H19N3O4 (245.1375)


   

Glutaminylvaline

Glutaminylvaline

C10H19N3O4 (245.1375)


   

Valyl-Gamma-glutamate

Valyl-Gamma-glutamate

C10H19N3O4 (245.1375)


   

Gly-Gly-Ile zwitterion

Gly-Gly-Ile zwitterion

C10H19N3O4 (245.1375)


A tripeptide zwitterion resulting from the transfer of a proton from the carboxy group to the amino group of Gly-Gly-Ile. Major microspecies at pH 7.3.

   
   
   
   
   
   
   
   
   

[(2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxyethylidene)amino]acetic acid

[(2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxyethylidene)amino]acetic acid

C10H19N3O4 (245.1375)


   

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-(c-hydroxycarbonimidoyl)propanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-(c-hydroxycarbonimidoyl)propanoic acid

C10H19N3O4 (245.1375)